Article info
Basic and translational research
Extended report
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE
- Correspondence to Dr Alessandra B Pernis, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA; pernisa{at}hss.edu
Citation
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE
Publication history
- Received May 5, 2016
- Revised August 4, 2016
- Accepted October 9, 2016
- First published November 9, 2016.
Online issue publication
October 31, 2019
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/